JP2004526406A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004526406A5 JP2004526406A5 JP2002512217A JP2002512217A JP2004526406A5 JP 2004526406 A5 JP2004526406 A5 JP 2004526406A5 JP 2002512217 A JP2002512217 A JP 2002512217A JP 2002512217 A JP2002512217 A JP 2002512217A JP 2004526406 A5 JP2004526406 A5 JP 2004526406A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- binding fragment
- polypeptide
- isolated antibody
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000427 antigen Substances 0.000 description 21
- 102000036639 antigens Human genes 0.000 description 21
- 108091007433 antigens Proteins 0.000 description 21
- 239000012634 fragment Substances 0.000 description 21
- 108090000765 processed proteins & peptides Proteins 0.000 description 14
- 229920001184 polypeptide Polymers 0.000 description 13
- 102000004196 processed proteins & peptides Human genes 0.000 description 13
- 206010061535 Ovarian neoplasm Diseases 0.000 description 6
- 206010033128 Ovarian cancer Diseases 0.000 description 5
- 239000008194 pharmaceutical composition Substances 0.000 description 5
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 125000003275 alpha amino acid group Chemical group 0.000 description 3
- 238000009007 Diagnostic Kit Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 108010066676 Abrin Proteins 0.000 description 1
- 102000009016 Cholera Toxin Human genes 0.000 description 1
- 108010049048 Cholera Toxin Proteins 0.000 description 1
- 102000016607 Diphtheria Toxin Human genes 0.000 description 1
- 108010053187 Diphtheria Toxin Proteins 0.000 description 1
- 108700004714 Gelonium multiflorum GEL Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101000762949 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) Exotoxin A Proteins 0.000 description 1
- 108010039491 Ricin Proteins 0.000 description 1
- 108010079723 Shiga Toxin Proteins 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 108700028325 pokeweed antiviral Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 125000006853 reporter group Chemical group 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61774700A | 2000-07-17 | 2000-07-17 | |
| US09/617,747 | 2000-07-17 | ||
| US09/636,801 US7202334B1 (en) | 1998-12-17 | 2000-08-10 | Compositions and methods for the therapy and diagnosis of ovarian cancer |
| US09/636,801 | 2000-08-10 | ||
| US09/667,857 | 2000-09-20 | ||
| US09/667,857 US6699664B1 (en) | 1998-12-17 | 2000-09-20 | Compositions and methods for the therapy and diagnosis of ovarian cancer |
| US09/827,271 | 2001-04-04 | ||
| US09/827,271 US6962980B2 (en) | 1999-09-24 | 2001-04-04 | Compositions and methods for the therapy and diagnosis of ovarian cancer |
| US09/884,441 | 2001-06-18 | ||
| US09/884,441 US20020119158A1 (en) | 1998-12-17 | 2001-06-18 | Compositions and methods for the therapy and diagnosis of ovarian cancer |
| PCT/US2001/022635 WO2002006317A2 (en) | 2000-07-17 | 2001-07-17 | Compositions and methods for the therapy and diagnosis of ovarian cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004526406A JP2004526406A (ja) | 2004-09-02 |
| JP2004526406A5 true JP2004526406A5 (https=) | 2008-10-02 |
| JP4942906B2 JP4942906B2 (ja) | 2012-05-30 |
Family
ID=46395398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002512217A Expired - Fee Related JP4942906B2 (ja) | 2000-07-17 | 2001-07-17 | 卵巣癌の治療および診断のための組成物および方法 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP4942906B2 (https=) |
| KR (1) | KR100935092B1 (https=) |
| CY (1) | CY1108790T1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202144388A (zh) * | 2020-02-14 | 2021-12-01 | 美商健生生物科技公司 | 在卵巢癌中表現之新抗原及其用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE413466T1 (de) * | 1998-09-02 | 2008-11-15 | Diadexus Inc | Verfahren zur diagnose, bewertung sowie bilddarstellung verschiedener krebserkrankungen |
| US6468546B1 (en) * | 1998-12-17 | 2002-10-22 | Corixa Corporation | Compositions and methods for therapy and diagnosis of ovarian cancer |
-
2001
- 2001-07-17 JP JP2002512217A patent/JP4942906B2/ja not_active Expired - Fee Related
- 2001-07-17 KR KR1020037000780A patent/KR100935092B1/ko not_active Expired - Fee Related
-
2008
- 2008-12-23 CY CY20081101495T patent/CY1108790T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007536932A5 (https=) | ||
| HRP20170879T1 (hr) | Genetski proizvodi koji su diferencijalno izraženi u tumorima i njihova primjena | |
| JP2002505843A5 (https=) | ||
| JP2021502810A5 (https=) | ||
| JPH07505775A (ja) | 癌腫抗原用抗体 | |
| US20070112179A1 (en) | Novel compounds | |
| JP2010537671A5 (https=) | ||
| JP2003510366A5 (https=) | ||
| JP2006500009A5 (https=) | ||
| JP2009197002A5 (https=) | ||
| JP2005514425A (ja) | Ｍｕｃ１８抗原に対する抗体 | |
| JP2002510968A (ja) | 組換え抗体−酵素融合タンパク質 | |
| US20100297664A1 (en) | Paratope and epitope of anti-mortalin antibody | |
| JP2020530285A5 (https=) | ||
| WO2002059264A3 (en) | Specific human antibodies for selective cancer therapy | |
| CA2579523A1 (en) | Atad3a-binding molecules for treatment, detection and prevention of cancer | |
| Shaw et al. | Isolation of a high affinity scFv from a monoclonal antibody recognising the oncofoetal antigen 5T4 | |
| AU6757098A (en) | Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels | |
| JP2008538182A5 (https=) | ||
| JP2008500833A5 (https=) | ||
| Pietersz et al. | Comparison of the biological properties of two anti-mucin-1 antibodies prepared for imaging and therapy | |
| JP2001517445A5 (https=) | ||
| JP2004526406A5 (https=) | ||
| JPWO2020233589A5 (https=) | ||
| CN117964760B (zh) | 抗人cll1/cd3的双特异性抗体及其应用 |